US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jyong Biotech

2.01

+0.02001.01%

Post-market: 2.010.0044+0.22%19:56 EST

Volume:187.28K

Turnover:373.51K

Market Cap:152.82M

PE:-49.88

High:2.10

Open:1.97

Low:1.88

Close:1.99

52wk High:67.00

52wk Low:1.43

Shares:76.03M

Float Shares:28.74M

Volume Ratio:0.33

T/O Rate:0.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0403

EPS(LYR):-0.0422

ROE:--

ROA:-5.44%

PB:-6.80

PE(LYR):-47.65

Loading ...

Overview Company News Filings

Jyong Biotech Reports Positive Phase II Results for MCS-8 in Prostate Cancer Prevention and Metabolic Health

Jyong Biotech Ltd: Wei (Vivi) Zhang Has Been Appointed as Company’s CFO

THOMSON REUTERS

Jyong Biotech Ltd: Zhang Will Be Replacing Alfred Ying

THOMSON REUTERS

Jyong Biotech Ltd. Appoints Wei Zhang as Chief Financial Officer

BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology

BUZZ-Jyong Biotech rises on prostate cancer drug mid‑stage trial data

Jyong Biotech Reports Phase II Trial Results Showing MCS-8 Lowers Cholesterol and May Prevent Prostate Cancer

Jyong Biotech Ltd - Mcs-8 Shows Potential in Alleviating High-Grade Malignancy Risk

THOMSON REUTERS

Jyong Biotech Ltd - Mcs-8 Shows 27.3% Reduction in Prostate Cancer Incidence

THOMSON REUTERS

Jyong Biotech Ltd - Phase Ii Trial Shows Significant Cholesterol Reduction With Mcs-8

THOMSON REUTERS

Jyong Biotech Subsidiary Announces Phase Ii Clinical Data on Cholesterol and Ldh Indicators for Mcs-8 (Pcp), Indicating Potential in Prostate Cancer Prevention and Metabolic Value

THOMSON REUTERS

After the recent decline, Jyong Biotech Ltd. (NASDAQ:MENS) CEO Fu-Feng Kuo's holdings have lost 33% of their value

Simply Wall St.

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM

BRIEF-Jyong Biotech In Talks With Investment Funds For Purchasing Co's Ordinary Shares

Jyong Biotech Ltd: Not Aware of Any Material, Unpublished Price-Sensitive Information or Corporate Developments to Explain Recent Trading Activity

THOMSON REUTERS

Jyong Biotech Ltd: in Talks With Certain Investment Funds That Are Interested in Purchasing Co's Ordinary Shares

THOMSON REUTERS

Jyong Biotech Addresses Share Price Volatility After Lock-Up Expiry

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:15 AM

BRIEF-Jyong Biotech Expands Regional Partnerships, Signs MoU With A Vietnam Pharmaceutical Distributor

Jyong Biotech Expands Regional Partnerships, Signs Mou With a Vietnam Pharmaceutical Distributor for Mcs‑2 Market Entry

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MENS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MENS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","market":"US","secType":"STK","nameCN":"Jyong Biotech","latestPrice":2.01,"timestamp":1771621200000,"preClose":1.99,"halted":0,"volume":187279,"hourTrading":{"tag":"盘后","latestPrice":2.0144,"preClose":2.01,"latestTime":"19:56 EST","volume":1606,"amount":3255.712,"timestamp":1771635416864,"change":0.0044,"changeRate":0.002189,"amplitude":0.0199},"delay":0,"changeRate":0.010050251256281305,"floatShares":28737800,"shares":76027667,"eps":-0.0403,"marketStatus":"Market Closed","change":0.02,"latestTime":"02-20 16:00:00 EST","open":1.97,"high":2.1,"low":1.88,"amount":373511.55985960003,"amplitude":0.110553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0403,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1744862400000,"exchange":"NASDAQ","adjPreClose":1.99,"preHourTrading":{"tag":"盘前","latestPrice":2.02,"preClose":1.99,"latestTime":"08:37 EST","volume":460,"amount":924.9237479999999,"timestamp":1771594666433,"change":0.03,"changeRate":0.015075,"amplitude":0.02005},"postHourTrading":{"tag":"盘后","latestPrice":2.0144,"preClose":2.01,"latestTime":"19:56 EST","volume":1606,"amount":3255.712,"timestamp":1771635416864,"change":0.0044,"changeRate":0.002189,"amplitude":0.0199},"volumeRatio":0.3325150615085522,"impliedVol":0,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","floatShares":28737800,"roa":"-5.44%","roe":"--","lyrEps":-0.042184,"volumeRatio":0.3325150615085522,"shares":76027667,"dividePrice":0,"high":2.1,"amplitude":0.110553,"preClose":1.99,"low":1.88,"week52Low":1.43,"pbRate":"-6.80","week52High":67,"institutionHeld":0,"latestPrice":2.01,"eps":-0.0403,"divideRate":0,"volume":187279,"delay":0,"ttmEps":-0.0403,"open":1.97,"prevYearClose":3.95,"prevWeekClose":1.55,"prevMonthClose":2.36,"prevQuarterClose":3.95,"fiveDayClose":1.47,"twentyDayClose":3.16,"sixtyDayClose":30.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MENS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-09","symbol":"MENS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767934800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MENS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MENS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MENS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MENS","date":"2026-02-19","current":-49.875931,"percent":0.952663,"low":-1671.474987,"twenty":-1305.747497,"median":-732.448389,"eighty":-92.64566,"high":-38.123637,"avg":-699.673726,"sd":535.909065,"marketCap":157645155},"quantilePoints":[{"date":"2025-06-20","current":-203.776286,"twenty":-230.665817,"median":-203.776286,"eighty":-192.159849,"marketCap":615200608},{"date":"2025-06-27","current":-224.00343,"twenty":-215.938323,"median":-202.579037,"eighty":-189.726725,"marketCap":676266355},{"date":"2025-07-03","current":-195.234603,"twenty":-221.003604,"median":-203.808474,"eighty":-195.578845,"marketCap":589413267},{"date":"2025-07-11","current":-224.00343,"twenty":-224.00343,"median":-203.776286,"eighty":-193.660924,"marketCap":676266355},{"date":"2025-07-18","current":-270.722038,"twenty":-248.100396,"median":-208.75841,"eighty":-195.234603,"marketCap":817309833},{"date":"2025-07-25","current":-289.655369,"twenty":-270.672861,"median":-224.00343,"eighty":-195.578845,"marketCap":874469558},{"date":"2025-08-01","current":-468.661403,"twenty":-288.081689,"median":-239.863168,"eighty":-197.84101,"marketCap":1414888775},{"date":"2025-08-08","current":-841.426716,"twenty":-379.453451,"median":-248.592171,"eighty":-201.860688,"marketCap":2540267255},{"date":"2025-08-15","current":-973.468255,"twenty":-555.508836,"median":-270.599094,"eighty":-203.789161,"marketCap":2938900662},{"date":"2025-08-22","current":-1061.25006,"twenty":-894.144977,"median":-285.475283,"eighty":-204.775034,"marketCap":3203913932},{"date":"2025-08-29","current":-1365.166899,"twenty":-1022.00643,"median":-288.917707,"eighty":-208.610878,"marketCap":4121438867},{"date":"2025-09-05","current":-1355.085515,"twenty":-1114.607628,"median":-347.684797,"eighty":-209.004298,"marketCap":4091003169},{"date":"2025-09-12","current":-1584.006693,"twenty":-1218.618003,"median":-441.613788,"eighty":-224.00343,"marketCap":4782116207},{"date":"2025-09-19","current":-1318.177851,"twenty":-1286.23704,"median":-523.494295,"eighty":-224.00343,"marketCap":3979578933},{"date":"2025-09-26","current":-1509.21812,"twenty":-1347.708893,"median":-786.347936,"eighty":-227.445854,"marketCap":4556329503},{"date":"2025-10-03","current":-1324.54586,"twenty":-1347.708893,"median":-940.396399,"eighty":-233.593039,"marketCap":3998803952},{"date":"2025-10-10","current":-1377.018254,"twenty":-1355.085515,"median":-1003.088768,"eighty":-246.133297,"marketCap":4157218108},{"date":"2025-10-17","current":-1489.859372,"twenty":-1369.101097,"median":-1041.824955,"eighty":-247.362734,"marketCap":4497885445},{"date":"2025-10-24","current":-1542.331766,"twenty":-1407.075256,"median":-1114.607628,"eighty":-248.592171,"marketCap":4656299601},{"date":"2025-10-31","current":-1146.49633,"twenty":-1407.075256,"median":-1138.789207,"eighty":-259.411217,"marketCap":3461272420},{"date":"2025-11-07","current":-953.163578,"twenty":-1404.508884,"median":-1114.607628,"eighty":-270.476151,"marketCap":2877600843},{"date":"2025-11-14","current":-974.050648,"twenty":-1403.763891,"median":-1074.835074,"eighty":-270.722038,"marketCap":2940658906},{"date":"2025-11-21","current":-835.482773,"twenty":-1377.018254,"median":-1042.570424,"eighty":-274.164462,"marketCap":2522322492},{"date":"2025-11-28","current":-692.839373,"twenty":-1370.684528,"median":-1023.721118,"eighty":-283.213119,"marketCap":2091682067},{"date":"2025-12-05","current":-743.528724,"twenty":-1368.302652,"median":-1011.760759,"eighty":-287.245672,"marketCap":2244713218},{"date":"2025-12-12","current":-678.575033,"twenty":-1365.754127,"median":-990.09803,"eighty":-288.081689,"marketCap":2048618024},{"date":"2025-12-19","current":-84.821879,"twenty":-1357.495212,"median":-973.759452,"eighty":-287.245672,"marketCap":256077253},{"date":"2025-12-26","current":-90.680447,"twenty":-1355.282225,"median":-962.970312,"eighty":-270.623683,"marketCap":273764270},{"date":"2026-01-02","current":-100.614541,"twenty":-1352.134866,"median":-921.074128,"eighty":-247.854509,"marketCap":303755300},{"date":"2026-01-09","current":-101.888143,"twenty":-1343.873049,"median":-841.426716,"eighty":-225.3804,"marketCap":307600304},{"date":"2026-01-16","current":-90.347797,"twenty":-1334.971925,"median":-784.679158,"eighty":-205.709406,"marketCap":266074262},{"date":"2026-01-23","current":-82.514173,"twenty":-1329.160825,"median":-777.915972,"eighty":-197.84101,"marketCap":243004240},{"date":"2026-01-30","current":-66.846925,"twenty":-1324.749636,"median":-757.793064,"eighty":-192.283954,"marketCap":196864194},{"date":"2026-02-06","current":-43.346053,"twenty":-1323.272258,"median":-744.420245,"eighty":-110.344859,"marketCap":127654126},{"date":"2026-02-13","current":-38.384758,"twenty":-1315.070263,"median":-743.019283,"eighty":-99.712528,"marketCap":113043111},{"date":"2026-02-19","current":-53.529764,"twenty":-1305.747497,"median":-732.448389,"eighty":-92.64566,"marketCap":157645155}],"updateTime":1771660494039},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MENS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610921957","title":"Jyong Biotech Reports Positive Phase II Results for MCS-8 in Prostate Cancer Prevention and Metabolic Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2610921957","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610921957?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:30","pubTimestamp":1770903036,"startTime":"0","endTime":"0","summary":"Jyong Biotech Ltd. announced the successful completion of a Phase II clinical trial for its lead investigational candidate, MCS-8. The company reported that the trial demonstrated positive outcomes in both oncological and metabolic health endpoints, specifically addressing prostate cancer risk and improvements in lipid profiles among the aging male population. The results of the Phase II study have already been presented. MCS-8, along with another candidate, MCS-2, remains under investigational status and has not received regulatory approval for commercial use in any jurisdiction. Jyong Biotech has also entered into non-binding agreements with pharmaceutical partners in South Korea and Vietnam to explore future commercialization opportunities for its pipeline products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL8lS6Yk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4585","BK4588","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","LU2095319765.USD","MENS","BK4112","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2609511273","title":"Jyong Biotech Ltd: Wei (Vivi) Zhang Has Been Appointed as Company’s CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2609511273","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609511273?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:33","pubTimestamp":1770413582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z21A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2609511227","title":"Jyong Biotech Ltd: Zhang Will Be Replacing Alfred Ying","url":"https://stock-news.laohu8.com/highlight/detail?id=2609511227","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609511227?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:33","pubTimestamp":1770413582,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z21A7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2609212511","title":"Jyong Biotech Ltd. Appoints Wei Zhang as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2609212511","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609212511?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:31","pubTimestamp":1770413511,"startTime":"0","endTime":"0","summary":"Jyong Biotech Ltd. has appointed Wei  Zhang as its new Chief Financial Officer, effective February 6, 2026. Zhang replaces Alfred Ying in the role. She brings extensive experience in finance, having previously served as CFO and director at Global Mofy AI Limited and as a consultant for a private company’s initial public offering.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jyong Biotech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL3Q3kzG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2607049612","title":"BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2607049612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607049612?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:12","pubTimestamp":1769782350,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX OncologyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL6N3YV0MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","SG9999002521.SGD","IE00BFXG1179.USD","RMD","MENS","XOM","SNDR","LU0498741890.SGD","CORT","APD","BK4532","IE00BWXC8680.SGD","TNXP","ALXO","LU2242646821.SGD","DVN","VEON","LU0070217475.USD","LU1150488135.SGD","BK4146","LXRX","PCVX","KYIV","AXP","LU0266512473.USD","LU0345780521.USD","VZ","BK4232","DECK","APA","LU0170899867.USD","LU0690374961.EUR","BK4581","CVX","CDE","IE00BGHQF524.EUR","NEM","BK4534","LU2404859667.USD","LU0690374615.EUR","SYK","HL","LU2404859741.USD","AU","LU0234572021.USD","IE000M9KFDE8.USD","IE00B2Q91V27.USD","LU2347655156.SGD","ALV"],"gpt_icon":1},{"id":"2607344046","title":"BUZZ-Jyong Biotech rises on prostate cancer drug mid‑stage trial data","url":"https://stock-news.laohu8.com/highlight/detail?id=2607344046","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607344046?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:43","pubTimestamp":1769780637,"startTime":"0","endTime":"0","summary":"BUZZ-Jyong Biotech rises on prostate cancer drug midstage trial data** Shares of drugmaker Jyong Biotech MENS.O rise 2.68% to $2.63 premarket** Co says its experimental drug, MCS8, helped reduce risk of prostate cancer — a disease caused by abnormal cell growth in the prostate gland** Co says men on MCS8 had a 27% lower chance of developing prostate cancer vs placebo in a midstage trial** Trial also showed potential benefit for cholesterol control, with patients seeing lower total cholesterol, per co** Co says no serious side effects reported; longterm use did not affect liver, kidney or blood pressure** MENS is considering expanding use of MCS8 for high cholesterol and heart disease, co says** Shares up ~43% in 2025  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL4N3YV1G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2607454045","title":"Jyong Biotech Reports Phase II Trial Results Showing MCS-8 Lowers Cholesterol and May Prevent Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2607454045","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607454045?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779854,"startTime":"0","endTime":"0","summary":"Jyong Biotech Ltd. has announced updated statistical analyses from its Phase II clinical trial of MCS-8 , an investigational plant-derived drug candidate, conducted in Taiwan. The results, which have already been presented, indicate that after two years of treatment, subjects receiving MCS-8 showed a statistically significant reduction in total cholesterol levels compared to baseline . Additionally, while a statistically significant increase in serum lactate dehydrogenase  levels was observed in the placebo group , no such increase occurred in the MCS-8 group. Based on these findings, Jyong Biotech is evaluating the feasibility of expanding MCS-8's indications to include lipid management, atherosclerosis, and cardiovascular diseases. MCS-8 remains an investigational drug and has not been approved for commercial use in any jurisdiction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL3DJp5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014039.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014005.SGD","BK4139","LU2095319765.USD","NDAQ","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","SG9999014021.USD","MENS","BK4112","BK4588"],"gpt_icon":0},{"id":"2607904514","title":"Jyong Biotech Ltd - Mcs-8 Shows Potential in Alleviating High-Grade Malignancy Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2607904514","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607904514?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA1NBYB4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2607504517","title":"Jyong Biotech Ltd - Mcs-8 Shows 27.3% Reduction in Prostate Cancer Incidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2607504517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607504517?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA1NBYB4:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2607045174","title":"Jyong Biotech Ltd - Phase Ii Trial Shows Significant Cholesterol Reduction With Mcs-8","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045174?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA1NBYB4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2607045106","title":"Jyong Biotech Subsidiary Announces Phase Ii Clinical Data on Cholesterol and Ldh Indicators for Mcs-8 (Pcp), Indicating Potential in Prostate Cancer Prevention and Metabolic Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045106?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nTUA1NBYB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2595739955","title":"After the recent decline, Jyong Biotech Ltd. (NASDAQ:MENS) CEO Fu-Feng Kuo's holdings have lost 33% of their value","url":"https://stock-news.laohu8.com/highlight/detail?id=2595739955","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595739955?lang=en_us&edition=fundamental","pubTime":"2025-12-29 18:34","pubTimestamp":1767004440,"startTime":"0","endTime":"0","summary":"Key Insights Insiders appear to have a vested interest in Jyong Biotech's growth, as seen by their sizeable ownership...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mens/jyong-biotech/news/after-the-recent-decline-jyong-biotech-ltd-nasdaqmens-ceo-fu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mens/jyong-biotech/news/after-the-recent-decline-jyong-biotech-ltd-nasdaqmens-ceo-fu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NQmain","PSQ","MNQmain",".IXIC","NVIW.SI","QLD","TQQQ","BK4139","JYB","QID","MENS","SQQQ","TSYW.SI","USAW.SI","USJW.SI"],"gpt_icon":1},{"id":"2593435883","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:39 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2593435883","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593435883?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:39","pubTimestamp":1766414359,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:39 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nAQN2LEQI6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2592198399","title":"BRIEF-Jyong Biotech In Talks With Investment Funds For Purchasing Co's Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592198399","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592198399?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:31","pubTimestamp":1766154678,"startTime":"0","endTime":"0","summary":"BRIEF-Jyong Biotech In Talks With Investment Funds For Purchasing Co's Ordinary SharesDec 19 (Reuters) - Jyong Biotech Ltd MENS.O:JYONG BIOTECH LTD: IN TALKS WITH CERTAIN INVESTMENT FUNDS THAT ARE INT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2592160537","title":"Jyong Biotech Ltd: Not Aware of Any Material, Unpublished Price-Sensitive Information or Corporate Developments to Explain Recent Trading Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2592160537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592160537?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:02","pubTimestamp":1766152930,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0V4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2592160372","title":"Jyong Biotech Ltd: in Talks With Certain Investment Funds That Are Interested in Purchasing Co's Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592160372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592160372?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:02","pubTimestamp":1766152930,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2592390160","title":"Jyong Biotech Addresses Share Price Volatility After Lock-Up Expiry","url":"https://stock-news.laohu8.com/highlight/detail?id=2592390160","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592390160?lang=en_us&edition=fundamental","pubTime":"2025-12-19 22:00","pubTimestamp":1766152815,"startTime":"0","endTime":"0","summary":"Jyong Biotech Ltd. has issued a statement addressing recent fluctuations in its share price and increased trading volume following the expiry of its lock-up period. The company emphasized that it remains in compliance with its disclosure obligations and is not aware of any material, unpublished price-sensitive information or corporate developments that would explain the recent trading activity. Jyong Biotech cautioned that share price movements can be influenced by various factors beyond its control, such as general market conditions and sector-specific news. The company reiterated its commitment to keeping shareholders informed of all material developments in accordance with applicable laws and regulations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL5hyQNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","NDAQ","SG9999014005.SGD","BK4588","SG9999014013.SGD","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","BK4139","MENS","LU2210149790.SGD","LU0314104364.USD","BK4112","SG9999014021.USD","IE00BGHQF748.EUR","LU2210150020.SGD"],"gpt_icon":0},{"id":"2592117289","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:15 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2592117289","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592117289?lang=en_us&edition=fundamental","pubTime":"2025-12-18 00:15","pubTimestamp":1765988107,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 11:15 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nAQN2LE0GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2588882405","title":"BRIEF-Jyong Biotech Expands Regional Partnerships, Signs MoU With A Vietnam Pharmaceutical Distributor","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882405","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882405?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:32","pubTimestamp":1764855141,"startTime":"0","endTime":"0","summary":"BRIEF-Jyong Biotech Expands Regional Partnerships, Signs MoU With A Vietnam Pharmaceutical Distributor Dec 4 (Reuters) - Jyong Biotech Ltd MENS.O:JYONG BIOTECH EXPANDS REGIONAL PARTNERSHIPS, SIGNS MOU","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2588821418","title":"Jyong Biotech Expands Regional Partnerships, Signs Mou With a Vietnam Pharmaceutical Distributor for Mcs‑2 Market Entry","url":"https://stock-news.laohu8.com/highlight/detail?id=2588821418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588821418?lang=en_us&edition=fundamental","pubTime":"2025-12-04 21:30","pubTimestamp":1764855056,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA02Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MENS"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}